Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus-infected patients with chronic kidney disease and end-stage renal disease
Keyword(s):
Keyword(s):
2021 ◽
Vol 18
(1)
◽
pp. 326
2019 ◽
Vol 26
(1)
◽
pp. 30-34
◽
Keyword(s):
2018 ◽
Vol 40
(2)
◽
pp. 130-135
◽